Tough Laws By EU On Herbal ED Cure

According to a directive by the European Union, it has been declared the EU will be imposing strict licensing laws and conditions on all imported herbal impotence drugs.

This law will be pass on May1st this year and it says that all herbal drugs manufacturing companies will have to abide by the new licensing law by selling on the high quality products and the side effects of these anti-impotence drugs will have to be mentioned very clearly on the products itself. It has been said by The Medicines and Healthcare Products Regulatory Authority that this law maybe tough on the companies, but it will serve the consumer well because it will prevent the user from getting harmed in any way.

It will save the consumer from the harmful interaction between the prescription drugs and the herbal impotence medicines. With the new rules coming in, it will protect the people from the potential side effects of the herbal pills. These Herbal ED drugs are also termed as Horny Goat weed and they have said to be introduced from Asia. They are also called as the Himalayan Viagra in many places. But all the alternative medical practitioners and retailers are actually worried about this imposed law because they feel it could have harmful effects on their business and maybe this could mark an end of this business itself.

Also the shop owners are concerning about paying thousands of dollars to acquire a license and this wont of any profit for them. But the Medical Authorities feel it is a good move and will pay rich dividends in the long run. Right now, only drugs like Viagra, Levitra and Cialis have been licensed by the European Union.

Generic Replacement of Protonix Approved by USA FDA

Wockhardt, a giant pharmaceutical company, has announced the launch of generic version of top selling heart burn drug Protonix. Protonix is manufactured and marketed by Pfizer Inc all over world.

USA FDA has given approval to the generic of Protonix called Pantoprazole. Application was filed by Wockhardt to seek permission to manufacture delayed release tablets of Protonix. Company will be making 40mg and 20mg dosage delayed tablets.

Protonix is used to treat acidity, gastrointestinal tract infection (stomach ulcers). It is patent protected until 2011. Pharmaceutical companies can seek approval before the patent expiry but they can not manufacture befire the date.

Protonix is the class of drug known as proton pump inhibitor. It inhibits action of proton pump and thereby limits acid production in stomach. Delayed release tablets of protonix will provide relief for longer than normal tablets.

Wackhardt is focused to provide generic version of brand drug on the day patent expires as it is important to keep up return optimal value.

The company is eying to maximize its already growing market share in USA. This is possible if it becomes the first company to provide generic replacement of brand drug.

To ensure security concerns, generic drugs will manufactured at USA FDA certified plant.

Hair Loss Drug may Cause Impotence

An anti-baldness drug called Finasteride is the only FDA approved drug to treat genetic hair loss. It is the top selling hair loss drug till to date. Finasteride has shown most promising result i.e. 9 of 10 men found hair loss stopped.

Finasteride (generic of Propecia) was approved by FDA to treat male pattern baldness in men with classification as prescription drug.

Recent, experiences of users of this drug are complaining about decreased libido and problematic ejaculation. Decrease in sex drive is there in the list of side effects of Propecia right from the day one. However, the maker company was not issuing any warning in label. Taking into account the complaints reported lately by many users of Propecia, Merck has started to issue warning on sexual side effect in drug label.

It was believed that sexual side effects of Finasteride come back to normal after stop taking the drug. However, many patients of hair loss have not got back their sexual life on track even after stop taking drug for 3 months.

Avanafil, More Effective and Safer Than Other ED Drugs

A pharmaceutical company Vivus Inc, is experimenting a new erectile dysfunction drug which is believed to be more effective than other impotence drugs such as viagra, cialis and kamagra. Company has claimed that the new drug has worked in more than 80% men, unlike viagra which is believed to be working in some men.
Representatives of Vivus Inc are about to meet concerned US FDA department for the approval application and process for their new weight-loss drug named as Qnexa.

Weight loss and impotency drug categories have huge market across the glob. Vivus Inc is trying to capture big chunk of the market by targeting these two drugs. So far, no drug has been successful like viagra.

Trial results of Avanafil were released in two parts. Latest release is an extended version of previous results of clinical trial. In second phase of trial patients were asked to continue drug after completion of first stage which lasted for a year.

Because Avanafil is metabolized fairly rapidly, men may be able to use it safely twice a day, at the beginning and end of the day, Tam said.

Unlike viagra, which is once a day drug, it is safe to take Avanafil twice a day as it is easy to metabolize. One can take it in morning and in evening as well.

US FDA had asked Vivus Inc to provide more data regarding heart issues and birth defects related to their weight loss drug called Qnexa.